Xiao-Liang Lan
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Interference and Gene Delivery
Papers in
-
- Extracellular vesicles in disease 2
- Circular RNAs in diseases 2
- RNA Research and Splicing 1
-
- MicroRNA in disease regulation 3
- Cancer-related molecular mechanisms research 3
- Cancer Genomics and Diagnostics 2
- Co-authors
- Liang Li (5 shared papers)Yanqing Ding (8 shared papers)Fuyao Song (2 shared papers)Wenting Liao (3 shared papers)Xiaoli Ren (2 shared papers)Zhicheng Zeng (3 shared papers)Zhao‐Chong Zeng (2 shared papers)Wenjie Liao (2 shared papers)
- Journals
- Nature Communications (1 paper)BMC Gastroenterology (1 paper)Cancer Immunology Immunotherapy (1 paper)Molecular Oncology (1 paper)Advances in Clinical and Experimental Medicine (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiao-Liang Lan
16 papers receiving 2.0k citations
Xiao-Liang Lan's Hit Papers
Peers
Comparison fields: 5 of 86
- Cancer Research 1.2k
- Molecular Biology 1.5k
- Oncology 307
- Immunology 167
- Immunology and Allergy 22
Countries citing papers authored by Xiao-Liang Lan
This map shows the geographic impact of Xiao-Liang Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Liang Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Liang Lan more than expected).
Fields of papers citing papers by Xiao-Liang Lan
This network shows the impact of papers produced by Xiao-Liang Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Liang Lan. The network helps show where Xiao-Liang Lan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiao-Liang Lan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis Hit paper breakdown → | 2018 | 753 |
| 2 | CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer Hit paper breakdown → | 2019 | 610 |
| 3 | 2016 | 371 | |
| 4 | 2018 | 110 | |
| 5 | 2017 | 38 | |
| 6 | 2019 | 28 | |
| 7 | 2021 | 22 | |
| 8 | 2016 | 19 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 6 | |
| 11 | Quality of laparoscopic total mesorectal excision: results from a single institution in China. | 2015 | 5 |
| 12 | 2014 | 5 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2021 | 1 |
About Xiao-Liang Lan
Xiao-Liang Lan is a scholar working on Molecular Biology, Cancer Research, Surgery, Pathology and Forensic Medicine and Oncology, having authored 16 papers that have together received 2.0k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Minimally Invasive Surgical Techniques (3 papers), Cancer Genomics and Diagnostics (2 papers), Extracellular vesicles in disease (2 papers), Circular RNAs in diseases (2 papers), Genetic factors in colorectal cancer (2 papers) and RNA Research and Splicing (1 paper). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.5k citations), Oncology (307 citations), Immunology (167 citations) and Immunology and Allergy (22 citations). Xiao-Liang Lan has collaborated with scholars based in China and United States. Frequent co-authors include Liang Li, Yanqing Ding, Fuyao Song, Wenting Liao, Xiaoli Ren, Zhicheng Zeng, Zhao‐Chong Zeng, Wenjie Liao, Guoxin Li and Fangfang Wang. Their work appears in journals such as Nature Communications, BMC Gastroenterology, Cancer Immunology Immunotherapy, Molecular Oncology and Advances in Clinical and Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.